Infants

This implementation starter kit describes and provides access to all the materials used in the Prevention of Mother-to-Child HIV Transmission (PMTCT) component of FHI 360’s Zambia Prevention, Care and Treatment Partnership (ZPCT). The program resulted in a significant increase in the use of PMTCT services as well as significant reductions in the mother-to-child transmission of HIV among ZPCT clinic clients. It now serves as a model for other countries. This kit is designed to be used by program designers to replicate the success of the ZPCT PMTCT program in other settings. 

This diagram outlines the process to test infants exposed to HIV at birth in Cameroon.

In response to a longstanding demand for a heat-stable and easy to administer formulation of ritonavir boosted lopinavir (LPV/r) for infants and young children, a new formulation in pellet form is now available.

This fact sheet provides simplified information to facilitate proper dosing and administration of lopinavir and ritonavir 40mg/10mg oral pellets.

The purpose of this framework is to provide operational guidance on monitoring and evaluation of pregnant and breastfeeding women receiving ART for life and their HEIs. This document is organized around a series of recommendations for the operationalization of monitoring, both routine (Section 1) and enhanced (Section 2), and the evaluation (Section 3) of programmes implementing lifelong ART for pregnant and breastfeeding women and their infants.

In 2014, only 50% of all HIV-exposed infants were tested by the second month of age. Innovative approaches such as use of assays at the point-of care and adding virological testing at birth could speed up identification and ART initiation. Operational research to fully inform how to implement such innovations remains critical.